Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Miravitlles

Showing results (141-150 of 564) with videos related to

Pageof 57
Sort By:
Archivos De Bronconeumologia|July 11, 2006
[Alpha1-antitrypsin deficiency: situation in Spain and development of a screening program]Cristian de la Roza, Beatriz Lara, Sara Vilà, et al.
Mediators of Inflammation|September 9, 2015
Mediators of Inflammation in Pulmonary DiseasesKostas Spiropoulos, Nikolaos Siafakas, Marc Miravitlles, et al.
International Journal of Chronic Obstructive Pulmonary Disease|October 22, 2013
COPD management: role of symptom assessment in routine clinical practiceThys van der Molen, Marc Miravitlles, Janwillem W H Kocks
International Journal of Chronic Obstructive Pulmonary Disease|October 25, 2012
Beyond FEV₁ in COPD: a review of patient-reported outcomes and their measurementPaul Jones, Marc Miravitlles, Thys van der Molen, et al.
Pulmonary Pharmacology & Therapeutics|January 15, 2022
Are short courses of antibiotic therapy as effective as standard courses for COPD exacerbations? A systematic review and meta-analysisCarl Llor, Ana Moragas, Marc Miravitlles, et al.
International Journal of Chronic Obstructive Pulmonary Disease|November 16, 2017
Characteristics of COPD patients according to GOLD classification and clinical phenotypes in the Russian Federation: the SUPPORT trialVladimir Arkhipov, Daria Arkhipova, Marc Miravitlles, et al.
The European Respiratory Journal|October 19, 2019
Is CRP-guided antibiotic treatment a safe way to reduce antibiotic use in severe hospitalised patients with exacerbations of COPD?Marc Miravitlles, Carl Llor, Lars Bjerrum, et al.
Therapeutic Advances in Respiratory Disease|November 3, 2009
Characterisation of exacerbations of chronic bronchitis and COPD in Europe: the GIANT studyMarc Miravitlles, Antonio Anzueto, Santiago Ewig, et al.
Chest|June 29, 2013
Is it possible to identify exacerbations of mild to moderate COPD that do not require antibiotic treatment?Marc Miravitlles, Ana Moragas, Silvia Hernández, et al.
American Journal of Respiratory and Critical Care Medicine|August 28, 2012
Efficacy of antibiotic therapy for acute exacerbations of mild to moderate chronic obstructive pulmonary diseaseCarl Llor, Ana Moragas, Silvia Hernández, et al.
Pageof 57

Showing results (141-150 of 564) with videos related to

Sort By:
Pageof 57
Archivos De Bronconeumologia|July 11, 2006
[Alpha1-antitrypsin deficiency: situation in Spain and development of a screening program]Cristian de la Roza, Beatriz Lara, Sara Vilà, et al.
Mediators of Inflammation|September 9, 2015
Mediators of Inflammation in Pulmonary DiseasesKostas Spiropoulos, Nikolaos Siafakas, Marc Miravitlles, et al.
International Journal of Chronic Obstructive Pulmonary Disease|October 22, 2013
COPD management: role of symptom assessment in routine clinical practiceThys van der Molen, Marc Miravitlles, Janwillem W H Kocks
International Journal of Chronic Obstructive Pulmonary Disease|October 25, 2012
Beyond FEV₁ in COPD: a review of patient-reported outcomes and their measurementPaul Jones, Marc Miravitlles, Thys van der Molen, et al.
Pulmonary Pharmacology & Therapeutics|January 15, 2022
Are short courses of antibiotic therapy as effective as standard courses for COPD exacerbations? A systematic review and meta-analysisCarl Llor, Ana Moragas, Marc Miravitlles, et al.
International Journal of Chronic Obstructive Pulmonary Disease|November 16, 2017
Characteristics of COPD patients according to GOLD classification and clinical phenotypes in the Russian Federation: the SUPPORT trialVladimir Arkhipov, Daria Arkhipova, Marc Miravitlles, et al.
The European Respiratory Journal|October 19, 2019
Is CRP-guided antibiotic treatment a safe way to reduce antibiotic use in severe hospitalised patients with exacerbations of COPD?Marc Miravitlles, Carl Llor, Lars Bjerrum, et al.
Therapeutic Advances in Respiratory Disease|November 3, 2009
Characterisation of exacerbations of chronic bronchitis and COPD in Europe: the GIANT studyMarc Miravitlles, Antonio Anzueto, Santiago Ewig, et al.
Chest|June 29, 2013
Is it possible to identify exacerbations of mild to moderate COPD that do not require antibiotic treatment?Marc Miravitlles, Ana Moragas, Silvia Hernández, et al.
American Journal of Respiratory and Critical Care Medicine|August 28, 2012
Efficacy of antibiotic therapy for acute exacerbations of mild to moderate chronic obstructive pulmonary diseaseCarl Llor, Ana Moragas, Silvia Hernández, et al.
Pageof 57